Using oligonucleotide-mediated 'loop-in' mutagenesis strategies in Ml 3, a heat-inducible ubiquitin (Ub) gene was extended by sequences coding for the C-terminal 11 amino acids of Ha-RAS. The resulting gene was transformed into AR1 3 and production of the Ub-peptide extension was induced by heat treatment. After one-step purification, the fusion protein (Ub-cRAS) was used as a substrate for farnesyl-protein transferase. Ub-cRAS was farnesylated on incubation in Xenopus egg extract or rabbit reticulocyte lysate. In contrast, when serine was substituted for the last cysteine in the RAS extension, transfer of the [3H]farnesyl group from [3H] farnesyl pyrophosphate to the modified Ub-cRAS was not observed. Farnesylation of Ub-cRAS permitted us to develop an easy membrane-binding assay for farnesyl-protein transferase enzyme activity. Using this assay, we partially purified the enzyme from rabbit reticulocyte lysate. We also detected methylation of the farnesylated Ub-cRAS terminus in Xenopus egg extract.
INTRODUCTION
Among the enzymes left to be discovered and characterized, many catalyse reactions in which proteins are the substrate. This class of enzymes includes the ever-expanding families of protein kinases [1, 2] , enzymes that add lipids to proteins [3, 4] and a wide variety of enzymes that modify specific amino acid side chains on cellular and secreted proteins [5] [6] [7] . Analysis of such enzymes requires peptides, either as potential substrates for measuring kinetic features of these catalysts or in the preparation of affinity matrices for purifying them. Recently, we described a method for synthesizing peptides as ubiquitin (Ub) extensions [8] . We have also demonstrated that Ub-peptide extensions can be used as substrates for a specific protein kinase [9] . In this regard, they offer distinct advantages over smaller peptide substrates commonly used to assay phosphotransferases.
The RAS proteins, members of a large family of small guanine nucleotide-binding proteins, are present in all eukaryotic organisms. In order to function, they have to be localized at the plasma membrane [10] . This localization requires a series of posttranslational modifications which include the farnesylation of cysteine (the fourth residue from the C-terminus), proteolytic cleavage of the C-terminal three amino acids and the methylation of exposed COOH of cysteine [3, [11] [12] . These modifications seem to require only the C-terminal consensus motif Cys-A-A-X (A, aliphatic amino acid; X, any amino acid) which is referred to as a CAAX box [13] .
Exploring further the utility of Ub-peptides as enzyme substrates, we have constructed a ubiquitin molecule extended by 11 amino acids from the C-terminus of Ha-RAS (PGCMSCKCVLS in the one-letter code). Here we describe the preparation and use of the Ub-peptide extension (Ub-cRAS) as a substrate for farnesyl-protein transferase (FPT) and carboxymethyltransferase. We also report on the partial purification and characterization of FPT from rabbit reticulocyte lysate. 
MATERIALS AND METHODS

Materials
Construction of expression vectors by oligonucleotide-mediated 'loop-in' mutagenesis
The ubiquitin coding gene in pNMHUb (generously given by David Echer of SmithKline French, Philadelphia, PA, U.S.A.) was digested with XbaI and KpnI and the resulting fragment was subcloned into the polylinker site of Ml3mpl8 using standard recombinant DNA techniques [14] . This construct (Ml3mpl8Ub) was used to prepare the single-stranded uracilcontaining template DNA. A synthetic oligonucleotide (AGA-CTAAGAGGTGGTCCCGGATGCATGTCTTGTAAATG-TGTACTATCATGAGGTACCGAGCTC) was designed to add 11 amino acids [the residues (PGCMSCKCVLS) in the one-letter code] to the C-terminus of ubiquitin, and oligonucleotidemediated 'loop-in' mutagenesis was performed according to the methods of Kunkel et al. [15] using the Bio-Rad mutagenesis kit.
Detection of the desired mutation (Ml3mpl8Ub-p) was performed by sequencing the resulting phage DNAs via dideoxy chain termination [16] . The mutated fragment was removed by XbaI and KpnI from the replicative form of the recombinant phage DNA, ligated into pNMHUb, and then transformed into the wild-type lysogen, MM294CI+. After the correct transformants had been confirmed by double-stranded DNA sequencing, the mutated plasmid was transformed into the expression strain, AR13, which contains a temperature-sensitive A repressor. Another single-stranded uracil-containing template DNA was prepared from M13mpl8Ub-p, and site-directed mutagenesis was performed to replace the last cysteine in the Ha-RAS extension with serine using the mutagenic primer (TCTTGTAAATCAGTACTATCAT). The construction of UbcRAS extensions in M13 is shown diagrammatically in Fig. 1 2).
Farnesylation of ub-peptide in vitro
The standard reaction mixture for FPT, adapted from the procedure of Schaber et al. [17] , contained the following components in a final volume of 20 ,ul: 50 mM-Hepes (sodium salt; pH 7.5), 5 mM-MgCl2, 5 mM-dithiothreitol (DTT), 12 The resulting autoradiogram (Fig. 4) [20] .
RESULTS
The Ub-cRAS extension proved to be an excellent substrate for FPT activities in Xenopus egg extract and rabbit reticulocyte lysate. Extracts prepared from these sources were incubated with either ubiquitin or Ub-cRAS in the presence of [3H]FPP. After termination of the reactions with SDS-sample buffer, the samples were electrophoresed on a 10 20 % polyacrylamide gel, and Xray film was exposed to the fluor-impregnated gel. It is clear from the resulting autoradiogram shown in Fig. 3(a) ) . Moreover, the extent of Ub-cRAS farnesylation was proportional to enzyme concentration (Fig. 3b) , thereby providing a quantitative assay for FPT. Farnesylation is just the first of several modifications to which the C-terminus of RAS is subjected. Several groups [21] [22] [23] [24] have presented evidence for subsequent removal of the last three amino acids from RAS or yeast a factor followed by methylation of the carboxy group at the farnesylated cysteine terminus. Some RAS termini are palmitoylated as well [13] . Clarke and colleagues have examined the carboxymethylation reaction using farnesylated peptides as substrate [25] . Although their assay is rigorous and quantitative, it is somewhat inconvenient because of the necessity of capturing gaseous methanol after methyl ester hydrolysis. For It is cumbersome to use gel electrophoresis in enzyme assays. For this reason, we examined the use of PVDF membranes as a way to capture the farnesylated product. Ub-cRAS was incubated with 0.5 p.l of Xenopus egg extract for 30 min at 25°C, and the reaction was terminated by adding 40 ,1u of 40 % methanol plus 1 % SDS. The reaction mixture was transferred to a PVDF membrane (see the Materials and methods section) and radioactivity in each slot was measured by liquid-scintillation spectroscopy. The data in Fig. 5(a) show that adsorption of farnesylated Ub-cRAS to PVDF membrane provides a highly discriminating assay for FPT. To determine whether the membranebinding assay is as quantitative as SDS/PAGE analysis of reaction products, we directly compared the two methods. According to the results in Fig. 5(b) and 5(c) , the much easier membrane-binding assay is equally as sensitive as the electrophoretic procedure, and both methods provide quantitative estimates of product formation.
With this assay in hand, 4 ml of reticulocyte lysate was chromatographed on Q-Sepharose to obtain a partially purified preparation of FPT. A single region of FPT activity eluted at approximately 300-340 mM-NaCl was detected (Fig. 6) . Fractions containing FPT activity were pooled, concentrated through PM 10 membrane, and then subjected to gel filtration on Sephacryl S-300. Again, a single peak of activity with an apparent molecular mass of approx. 180 kDa was observed (Fig. 7) . Since the pig brain FPT has been purified to homogeneity by affinity chromatography [26] , we did not pursue complete purification of the rabbit reticulocyte enzyme.
DISCUSSION
The studies presented above indicate that Ub-cRAS extensions provide suitable substrates for assaying three enzymes that modify the C-terminus of the Ha-RAS protein. Data evidence that removal of the three terminal residues is needed for carboxymethylation [21] [22] [23] [24] , the data in Fig. 4 indicate that the Ub-cRAS extension is also a suitable substrate for the processing proteinase. Moreover, we have observed that Ub-cRAS can accept [14C]palmitate from palmitic acid in Xenopus egg extract (results not shown), so it seems that Ub-cRAS extensions are subjected to all known modifications of the C-terminus of RAS.
Because small peptides can also be used in assays for lipid modification [26] [27] [28] [29] [30] , one might question potential complications due to the N-terminal ubiquitin moiety. As enzyme substrates, Ub-peptide extensions offer several distinct advantages over short peptides. First, they are extremely inexpensive to synthesize in large quantities. The single-stranded procedure outlined in Fig. 1 lowers the initial cost for peptides to about $8 (-£4.60) per residue. Expenses for subsequent rounds of synthesis are decreased almost to the price of bacterial growth medium. Second, Ub-peptides can, in certain cases, be purified from bacterial extracts by simple acid extraction (see Fig. 2 ). Third, some assays may require electrophoretic analysis for accurate quantification. For example, the methyl-transferase activity detected in Fig. 4 is not specific to the Ub-cRAS extension. The fact that Ub-peptides migrate on SDS/polyacrylamide gels in a region (approx. 9 kDa) virtually devoid of other proteins decreases greatly any possible confusion from endogenous proteins that may also become modified. Fourth, the presence of ubiquitin at the N-terminus of the peptide substrate is probably crucial for product capture by PVDF membranes. We did not directly compare Ub-cRAS peptides with cRAS peptide alone in membrane binding, but it seems very likely that farnesylated short peptides will adsorb to PVDF membranes much less well than Ub-peptide extensions. We believe these advantages far outweigh any potential complications resulting from the presence of ubiquitin at the peptide's N-terminus.
Although the thrust of these studies was to assess further the suitability of Ub-peptides as enzyme substrates, we also made several observations relevant to the biochemistry of RAS modification. In Fig. 4 it is shown that the Ub-cRAS becomes methylated in a FPP-stimulated reaction whereas the Cys -+ Ser variant does not. In the light of previous studies, we interpret these results as indicating that in Xenopus egg extract Ub-cRAS is farnesylated, processed by proteolysis and the C-terminal is composed of similar subunits, the holoenzyme is probably a tetramer. Rabbit reticulocyte lysate (4 ml) was chromatographed on QSepharose. Every other fraction (10 ,l each out of 8 ml fraction) was incubated with 1 nmol of Ub-cRAS under standard assay conditions. FPT activity was measured using PVDF membrane as described in carboxy group is methylated. Both the failure of the serine variant to become carboxymethylated and the absence of UbcRAS methylation when excess FPP is omitted would indicate that farnesylation precedes methylation, an inference for which there is already substantial evidence (see ref. [12] for a review). It should be noted that carboxymethylation was not observed when reticulocyte lysate was substituted for Xenopus egg extract under identical reaction conditions (results not shown). This observation is in accord with studies that place the carboxymethyltransferase on the intracellular surface of the plasma membrane [24] [25] .
We also partially purified and sized rabbit reticulocyte FPT. Several groups have characterized FPT from various tissues, and there are substantial differences in reported molecular mass. Reiss et al. [26] found that the rat brain FPT has an apparent size of about 100 kDa. Manne et al. [31] observed two peaks of pig kidney FPT activity with apparent molecular masses of approx. 300 kDa and approx. 100 kDa, whereas Schaber et al. [17] reported a molecular mass of 190 kDa for bovine brain FPT. Our estimate for the molecular mass of rabbit reticulocyte FPT, 180 kDa, is in close agreement with that reported for the bovine brain enzyme. FPT from rat brain consists of two non-identical subunits of about 50 kDa [32] . Assuming that reticulocyte FPT These studies were supported by a grant (no. CD395) from the American Cancer Society. We thank Kim Marshall and Linda Van Orden for expert word processing.
